(b)(6) 2022: information was received from a patient who was implanted with an implantable neurostimulator (ins) for spinal pain indications.It was reported that the pt mentioned that the implanting surgeon could only implant one cervical lead in the left side, but they couldn't implant the second lead in the right cervical region.(b)(6) 2022: additional information was received from the manufacturer representative.The issue with implanting the second lead was because there was too much scar tissue, and not enough space from a previous lead in the canal space.The issue was resolved, healthcare provider (hcp) decided not to place the second lead.(b)(6) 2023: additional information was received from the patient.They reported that the cervical lead migrated.Pt noted their healthcare provider (hcp) fixed the lead.(b)(6) 2023: additional information was received from a manufacturer representative (rep).The rep reported that according to the x-rays in the system the cervical lead did not migrate.Healthcare provider (hcp) only implanted 1 lead and never got it to the cervical region where it was for the trial.The patient apparently did well and got good pain relief for the past couple of years and recently started complaining of pain returning.The lead did not migrate.It was just never placed cervically.
|
Section d information references the main component of the system.Other relevant device(s) are: product id: neu_unknown_lead, serial/lot #: unknown.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|